FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/096889 [Registered on: 04/11/2025] Trial Registered Prospectively
Last Modified On: 04/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Treatment of hypothyroidism with ayurveda medicine Ghanadi vati & Kanchnara gudika  
Scientific Title of Study   A RANDOMIZED CLINICO-COMPARATIVE TRAIL TO EVALUATE THE EFFICACY AND SAFETY OF GHANADI VATI AND KANCHNARA GUDIKA IN THE MANAGEMENT OF DHATVAGNIMANDYA W.S.R. TO HYPOTHYROIDISM 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Divya singh charan 
Designation  Ph.D Scholar 
Affiliation  Maharao Skekhaji Regional Ayurveda Research Institute Bani Park,Jhotwara road, Jaipur  
Address  Kayachikitsa department,OPD-1(Room no-1) Mahatma Jyotiba Fule Ayurveda Mahavidyalaya Chomu, Jaipur
Room no-11C,Maharao Skekhaji Regional Ayurveda Research Institute Bani Park,Jhotwara road, Indra colony Jaipur
Jodhpur
RAJASTHAN
303702
India 
Phone  09828770266  
Fax    
Email  divyacharan.dr@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Avinash Jain 
Designation  Research Officer (Ayurveda) 
Affiliation  Maharao Skekhaji Regional Ayurveda Research Institute 
Address  Room no-11C, Maharao Skekhaji Regional Ayurveda Research Institute Bani Park,Jhotwara road, Indra colony Jaipur
-
Jaipur
RAJASTHAN
302016
India 
Phone  7425063398  
Fax    
Email  vaidyaakjain@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Divya singh charan 
Designation  Assistant professor  
Affiliation  Dr Sarvepalli Radhakrishnan Rajasthan ,jodhpur,pincode 342037 
Address  Kayachikitsa department opd no -1 Mahatma Jyotiba Fule Ayurveda Mahavidyalaya Chomu, Jaipur
-
Jaipur
RAJASTHAN
303702
India 
Phone  9828770266  
Fax    
Email  divyacharan.dr@gmail.com  
 
Source of Monetary or Material Support  
Nil 
 
Primary Sponsor  
Name  Dr Divya Singh Charan  
Address  Kayachikitsa department opd-1,Mahatma jyotiba fule ayurveda mahavidyalaya Chomu, Jaipur 303702 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Divya singh charan  Maharo skekhaji regional ayurveda research institute Bani park jhotwara road indra colony jaipur  Roomno-11c,Maharo skekhaji regional ayurveda research institute Bani park jhotwara road indra colony jaipur
Jaipur
RAJASTHAN 
09828770266

divyacharan.dr@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee M.S.Regional Ayurveda Research Institute  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E00-E89||Endocrine, nutritional and metabolic diseases. Ayurveda Condition: AGNIVAISHAMYAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Ghanadi vati , Reference: Bhaisajya ratnavali , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 375(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: lukewarm water), Additional Information: Chapter-10 Agnimandhya shlok no- 300-302
2Comparator ArmDrugClassical(1) Medicine Name: Kanchnar gudika, Reference: Bhaisajya ratnavali , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: lukewarm water), Additional Information: Chapter no-44 Galganda adhyaye Shlok no -60-62
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients having sign and symptom of Dhatwagnimandya (Hypothyroidism) will be selected for the present study. Patients having age between 18 to 60 years of either sex.Already diagnosed and Fresh patients of TSH level 5-12 mlU/L. Patients, willing to give written informed consent to participate in the study.  
 
ExclusionCriteria 
Details  Participants will be excluded if they have TSH levels more than12 mlU/L. congenital hypothyroidism and secondary hypothyroidism. any type of thyroid surgery.Patients below 18 years and above 60 years of age. uncontrolled Diabetes mellitus. poorly controlled hypertension. clinical evidence of Heart failure.Other exclusion includesAlcoholics and/or drug abusers.
Pregnant/lactating woman. Any other condition which the Investigator thinks may jeopardize the study.  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The Primary outcomes are Any changes in the value of serum TSH.  Total study time 90days follow up at every 1 month 
 
Secondary Outcome  
Outcome  TimePoints 
Change in T3 & T4.
Changes in status of Agni (Jatharagni Assessment).Change in RAND 36- Item Health Survey 1.0 Questionnaire.
Change in Swasthya Assessment Scale. 
at base line,12 weeks 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
It is a randomized, prospective, open-label, interventional comparative clinical trial.
The trial consists of three groups: one will receive Ghanadi Vati, the second
group will receive Kanchnara Gudika and the third group will receive
both Ghanadi Vati,and Kanchnara Gudika together
 
Close